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Introduction
During the second half of the 20th century, the pharmaceutical 
science and practice were extensively shaped by the advances 
made in chemistry and biology which led to the discovery of 
new technologies for development of innovative, safer and 
more effective medicinal products (11, 18). At the beginning 
of 21st century a large number of new medicinal products were 
discovered as agents acting selectively on individual tissues or 
sites within the cells, thus achieving major safety and efficacy 
benefits. Genetic engineering and related technologies have 
promoted the development of a range of modern biotechnology 
medicinal products, jointly termed biopharmaceuticals or 
biotechnology-based drugs (17).
Biotechnology is an interdisciplinary science applied to 
living cells with the aim to produce substances and compounds 
essential to life and human wellbeing. Production methods 
used in biotechnology are focused on adding, subtracting, 
multiplying or dividing bio-molecules. in contrast, conventional 
pharmacy education lays emphasis on production of synthetic 
molecules in order to treat the symptoms of diseases (10).
Some medical applications of biotechnology for example 
include isolation of new antibiotics, improvement of insulin 
production, and development of malaria vaccines, of diagnostic 
tests for serious genetic diseases (e.g. hereditary cancers, 
diabetes and huntington’s chorea) and approaches for detection 
and treatment of AiDS (15). thus near 25% of all new medicinal 
products now approved are biopharmaceuticals (17).
Pharmaceutical biotechnology, pharmacogenomics, 
pharmacogenetics, combinatorial chemistry, in close relation 
to high-throughput screening technologies, and bioinformatics 
are major advances that open a new horizon to pharmaceutical 
sciences and education (16).
Biotechnology influenced not only the pharmaceutical 
science and education but also the pharmacy practice. in some 
countries specialty pharmacies have been developed to offer 
services, medicinal products for individual patients suffering 
from chronic diseases, or people with acute conditions 
requiring biotechnological intervention. Such pharmacies 
are specialized in high-cost, high-risk conditions and deliver 
services and products directly to patients or institutions. they 
also work in close cooperation with third-party payers in order 
to ensure that drugs are being prescribed appropriately, used 
correctly, and discontinued when no longer needed (5).
As defined by Speedie et. al (13), major areas of impact 
of biotechnology on pharmacy practice can be identified as 
dispensing the proteins and proteinaceous medicinal products 
requiring often new delivery systems and special home health 
care (most of the medicines are administered parenterally); 
new medicines classes in the area of immunotherapy; new 
diagnostic tools based upon monoclonal antibodies or 
hybridization technology as well as new economic and ethical 
considerations concerning limited supply and/or increased 
costs of therapy, the appropriate use of diagnostics, and the 
role of pharmacy in the distribution and use of biotechnology 
derived medicinal products.
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The aim of our study was to review the scientific literature on biotechnology inclusion in pharmacy curriculum and to systematize 
the approaches that the colleges and schools of pharmacy in the United States of America (USA) apply to address this education.
For the period 1989-2010 a total of 18 publications satisfying the search criteria were found. The articles were systematized in 
historical order following the date of publication.
The developments in modern pharmacy practice are taken into account and implemented in the pharmacy curriculum in 
the colleges and schools of pharmacy in the United States. In 78% of the USA universities this is achieved by integrating 
biotechnology content in the PharmD curriculum. Together with the development of biotechnology science the educational 
programs are improving but they still delay providing knowledge, especially for undergraduate students.
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According to some authors (5), approximately 1% of the 
population needs a biotech medicinal product, either for acute 
treatment or for chronic maintenance. clinical conditions 
that often require biotechnological intervention are organ 
transplantations, diabetes, hiV/AiDS, multiple sclerosis, 
haemophilia, growth hormone deficiency, infertility, hepatitis 
B and c, cancer etc. (5) Many vaccines and diagnostics are 
biotechnology derived products.
It is evident that biotechnology has a significant impact 
on modern pharmaceutical science and practice, as well as on 
the increasing number of biopharmaceuticals on the market. 
Biotechnological methods applied in pharmacy science and 
practice brings hope for new therapeutic interventions not 
only for diseases that require better treatment, but also for 
untreatable ones.
these developments in pharmaceutical science and practice 
call for a paradigm shift in pharmacy education.
The aim of our study was to review the scientific literature 
on biotechnology inclusion in pharmacy curriculum and 
secondly, to systematize the approaches that the colleges and 
schools of pharmacy in the United States of America (USA) 
apply to address this education.
Materials and Methods
literature search was done through MeDline/PubMed, 
Scopus database search as well as by internet-based search with 
the key words “pharmacy”, “biotechnology”, “biotechnology 
pharmaceutical education”, and “biopharmaceuticals”. For 
the period 1989-2010 a total of 18 publications satisfying 
the search criteria were found. We have limited the search 
only to publications related to north America as european 
publications will be reviewed in a separate work. the articles 
were systematized in historical order following the date of 
publishing.
the information for the curricula of the biotechnology 
related disciplines included in pharmacy education in USA 
universities was taken from the universities’ websites. in 
total, 116 pharmacy schools’ internet sites were observed and 
available information was classified according to the following 
criteria:
• availability of topics named biotechnology in the 
regular education;
• availability of postgraduate education courses on 
biotechnology;
• integrated elective or required education on 
biotechnology topics.
Results and Discussion
Publications devoted to biotechnology in pharmaceutical 
education
the presence of biotechnology in the pharmaceutical education 
in North America has been widely discussed in the scientific 
literature.
In 1989 Stewart and Fleming shared the opinion that the 
curriculum of students undergoing training in pharmacy 
should cover immunoglobulins, immunomodulators, growth 
hormones, targeted drug-delivery systems, and advanced 
diagnostic techniques that use biotechnology products due to 
the proliferation of biotechnology-derived products (14).
in her publication “the impact of biotechnology upon 
pharmaceutical education”, Speedie (13) reviewed the 
professional curriculum of clinical pharmacy, pharmacy 
administration, pharmacology, medicinal chemistry, 
pharmaceutics, basic sciences, and continuing education, 
as well as the research in pharmacy schools, and graduate 
education. She defined a significant impact of biotechnology 
on pharmacy practice and education that needs to be 
more carefully examined. henkel et al. (6), Block (2) and 
Hudson (7) have outlined specific curricula implications 
for undergraduate and graduate pharmacy study derived 
from the biopharmaceutical industry development that 
are the pharmacokinetic and physicochemical aspects of 
biotechnology-derived pharmaceuticals.
Speedie et al. (12) discussed approaches that were taken 
in incorporating biotechnology-related material into pharmacy 
curricula in the 90s. The authors identified three models of 
inclusion of biotechnology material into pharmacy curriculum: 
integration throughout an entry level PharmD curriculum, 
a separate biotechnology course, and a course focused on 
immunotherapeutics which addresses biotechnology issues in 
that context. An example of integrated biotechnology into the 
basic pharmaceutical sciences is given with the University of 
Mississippi where biotechnology is incorporated into numerous 
courses throughout the curriculum (biochemical foundation 
of therapeutics, pharmacogenetics, pharmacoimmunology, 
medicinal chemistry, human physiology and pathophysiology, 
basic pharmaceutics, pharmacology, patient assessment 
and therapeutic monitoring, biomedical ethics etc.). the 
University of Florida College of Pharmacy has developed and 
implemented stand-alone biotechnology course for the entry 
level PharmD curriculum. it is an elective course offered 
during the last semester of the third year after completion of 
core courses. the University of texas used the third approach 
– specialized coursework in immunology, as large percentage 
of the biotechnology-derived products are related to the 
immune system, either as immunomodulators, vaccines, or 
monoclonal antibodies. the course has begun as an elective 
course and during the following year has become required. 
Speedie at al. (12) also presented the results of a survey 
concerning progress made in schools across the USA and 
perceived barriers to further progress. the survey represented 
72 colleges/schools of pharmacy in the USA. the survey results 
showed that biotechnology-derived products were brought 
to pharmacy students’ attention throughout various subjects 
such as biochemistry, pharmacology, applied therapeutics, 
pharmacoeconomics, etc. Some barriers to implementing 
a biotechnology course in the pharmacy curriculum were 
identified as “competition with other topics”, “lack of teaching 
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tools” and “lack of information resources”. lack of personnel 
and administrative support was identified as a tertiary concern.
During 1996, a study was undertaken to assess pharmacists’ 
evaluations of the program on pharmaceutical biotechnology. 
out of the 145 total respondents: 93.1% considered the program 
to be a valuable learning experience; 85.7% considered the 
method a convenient and time saving means for professional 
continuing education; and 84.1% indicated that they would 
recommend the program to a colleague. Pharmacists agreed: 
1) that course materials were presented in sufficient detail 
(94.5%); 2) with the quality of the audio cassettes (95.8%), 
printed materials (95.8%), and review check tests (81.9%); 
and 3) with the easy accessibility of an audio cassette tape 
recorder (95.9%). the importance of up-to-date biotechnology 
knowledge for pharmacists is confirmed by the development 
of a distance learning pharmaceutical biotechnology course 
which provides pharmacists with a practical review of cell 
molecular biology, recombinant DnA technology, and products 
developed through pharmaceutical biotechnology (4).
A survey of 52 pharmaceutical faculties/pharmaceutical 
biotechnology companies in europe, Asia and America 
regarding their views about the creation of a satisfactory 
program of pharmaceutical biotechnology was done in 2001 
(3). All participants in the survey were in agreement about 
the inclusion of pharmaceutical biotechnology courses in 
undergraduate teaching programs of pharmacy faculties. 
Most of the responding faculties of europe and Japan stated 
that there were pharmaceutical biotechnology courses in their 
pharmacy curriculum. Respondents from the USA pointed 
out that pharmaceutical biotechnology courses should be 
included as 2-3 hrs/week in undergraduate programs as a 
mandatory course and the 2nd and 3rd years were suggested as 
the most appropriate initiation time. Most of the respondents 
suggested a 2-4 hrs/week for the duration of courses while 
the generally suggested initiation time was the 3rd year of the 
pharmacy undergraduate program. however, almost 50 % of 
the respondents suggested that these should be optional.
Biotechnology is often associated with pharmacogenetics 
and pharmacoeconomics. in 2005 latif et al. (8) researched 
the extent and depth to which pharmacogenetics and 
pharmacogenomics were being taught in pharmacy schools in 
the USA. A survey was sent to 85 deans at colleges and schools 
of pharmacy in the USA. the results showed that although 
most of the surveyed schools provided some instruction 
in pharmacogenetics or pharmacogenomics and planed to 
increase it in the coming years; many did not provide the depth 
recommended by the American Association of colleges of 
Pharmacy (AAcP). Sixty-eight percent of the sampled colleges 
and schools planned to increase their pharmacogenomics/
pharmacogenetics instruction during the following 3 years.
two policy resolutions were passed by 2008, when the 
AAcP house of Delegates recommended greater focus on 
the advancement of education in biotechnology. The first 
one focused on the responsibility of pharmacy curriculum to 
address up-to-date issues related to biotechnology advances 
in tailored medicine. It discussed specific competencies such 
as biology, bioengineering, genetics/genomics, proteomics, 
nanotechnology, cellular and tissue engineering, bio-imaging, 
computational methods, and information technologies. the 
second policy concerned faculty development in biotechnology 
areas and stated that “faculty development programs and 
collaborative research and teaching strategies should be 
expanded such that faculty at colleges and schools of pharmacy 
are prepared to lead and contribute significantly to education 
and research…” in the abovementioned areas (1).
Another study conducted in 2010 revealed that 69 of 
75 (92.0%) colleges out of 109 surveyed reported to be 
teaching pharmacogenomics within any of their programs, 
and 67 (89.3%), within their current PharmD curriculum. As 
discussed by the authors, this was an increase compared with 
earlier results (8) that 78% of the programs were providing 
this content in any program, and 39% were providing it in the 
PharmD curriculum. the main conclusion the authors made 
was that at the time of their study the majority of the colleges 
of pharmacy were providing some level of biotechnology 
instruction within their curriculum, indicating an increased 
awareness of the need to do so, and thus demonstrating 
alignment with AAcP recommendations about including this 
material within the PharmD curriculum (9).
Biotechnology in pharmacy curriculum in the USA
there are 115 schools of pharmacy in the USA. Unlike 
pharmacy education in most eU countries, the schools of 
pharmacy in the USA offer PharmD programs (leading to 
Doctor of pharmacy degree). the eligible candidates shall be 
graduated from a school or college of pharmacy accredited 
by the American council on Pharmaceutical education or 
recognized by the relevant State Board of Pharmacy, or 
have completed equivalent education and experience outside 
the United States, approved by the relevant State Board of 
Pharmacy. PharmD duration is 4 years. During the two pre-
pharmacy years students study general chemistry, general 
biology, organic chemistry, computers, anatomy, physiology, 
physics, economics, public speaking, Afro-American 
history etc.
At the time of the study of Speedy et al. (12) many schools 
of pharmacy had already made progress in incorporating 
biotechnology material into their curricula either through 
individual courses or integration throughout the curriculum.
the results for the studied schools of pharmacy are 
presented in Fig. 1. in 90 universities (78%) biotechnology 
is incorporated into different topics (Table 1). twenty-two 
universities (19%) offer a separate biotechnology course. three 
universities developed elective biotechnology courses besides 
the biotechnology topics incorporated in different subjects.
in the universities where biotechnology is integrated in the 
curriculum, biotechnology-related knowledge is distributed 
in cellular biology, biochemistry, pharmacogenomics, etc. 
(Table 1). 
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Fig. 1. content of biotechnology in PharmD programs in the USA. 
topics addressed in cellular and molecular biochemistry 
include DnA/RnA/protein structure and synthesis, signal 
transduction pathways, gene regulation, organelle function and 
regulation, enzyme kinetics, energy catalysis, and bacterial/
viral biology and it serves as a foundation for understanding 
the cellular and biochemical actions of drugs.
Besides the courses on biochemistry and molecular 
biology, some universities offer a laboratory course on 
experimental methods of biochemistry and molecular biology 
with emphasis on problem solving (e.g. Samford University 
in Alabama). Pharmacogenomics is focused on gene structure, 
DnA replication, transcription, translation, and recombinant 
DnA technology used in production of biotechnology-derived 
medicinal products.
in addition, some universities offer specialized 
pharmaceutical biotechnology courses in PharmD programs 
during the professional years (Medical University of South 
carolina, West Virginia University, University of Wisconsin-
Madison, University of iwova, Massachusetts college of 
Pharmacy and health Sciences, University of oklahoma, 
Palm Beach Atlantic University etc.). the pharmaceutical 
biotechnology course teaches recent developments in the 
synthesis, structure, and function of biologically active peptides 
and their relationship to the treatment of disease in man.
Principles of immunology as applied to drug development 
and utilization with emphasis on immunotherapeutic agents. 
the specialized combined biotechnology and immunology 
course at Wilkes University, School of Pharmacy, Pennsylvania, 
focuses on discussion of non-specific host defence mechanisms 
and a detailed description of specific immunity. Products that 
impair artificial active and passive immunity are presented. 
the concept of biotechnology is discussed together with the 
currently available immunology-related products of genetic 
engineering. the various immunological disorders and the 
immunology of cancer and HIV are discussed. At Ferris State 
University college of Pharmacy the biotechnology course 
is combined with a molecular biochemistry course, while at 
husson University in Main biotechnology is combined with 
pharmacogenomics.
in Palm Beach Atlantic University biotechnology content 
is combined with immunology. this combination provides an 
overview of infectious organisms, pathogenic mechanisms; 
antimicrobial agents that are used to treat such infections, 
mechanisms by which organisms develop resistance, and 
epidemiologic patterns of common infections. Students are 
focused on application of biotechnology in creating diagnostic 
and therapeutic immune agents. in Massachusetts college of 
Pharmacy and health Sciences pharmaceutical biotechnology 
is taught during the second professional year, while in some 
universities it is taught during the first professional year 
(Sullivan University in Kentucky).
the third approach is an integrated biotechnology content 
combined with an elective biotechnology course. As an 
elective, the Scaggs School of Pharmacy offers a course on bio 
business for 3rd year pharmacy students. the students analyze 
start-up proposals, the genesis of the biotech industry, biotech 
categories and growth strategies, the process of spinning out 
TABLE 1 
Subjects addressing biotechnology
Subject Content/Subject matter
Biology Molecular biology terminology. immunology. Monoclonal antibodies.
Microbiology Drug-producing microorganisms. Biopharmaceutical products. 
Biochemistry Protein chemistry. Gene expression. Molecular control mechanisms. Biotechnology/hybridization technology.
Genetics Gene expression. Functional and structural genomics. 
Medical devices Biopharmaceutical products delivering systems: insulin pumps, implants etc.
Pharmaceutical technology Drug delivery of proteins across membranes. liposomal drug delivery. Manufacture of biopharmaceuticals. targeted dosage forms. 
Pharmaceutical chemistry Biotechnology-derived products. Manufacture of biopharmaceuticals. Recombinant DnA and hybridization technologies. 
Pharmacology
Biotechnology-derived products. immunomodulators, trombolytics, blood coagulation factors, 
insulin products, anticancer drugs, interferons, vaccines, antibodies etc. Molecular mechanisms 
of biopharmaceuticals’ actions. Genes involved in drug response and adverse drug reactions. 
Personalized medicine. 
Social pharmacy and 
pharmaceutical legislation
Biopharmaceuticals and ethics. Pharmacoeconomics of biopharmaceuticals. handling 
of biopharmaceuticals during storage and transportation. Dispensing. Pharmacogenetics. 
Pharmacovigilance of biopharmaceuticals. 
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viable product concepts from academia, financing techniques, 
business development etc. in the University of Washington the 
biotechnology elective course is focused on biomedical ethics 
and pharmaceutical biotechnology and is taught during the last 
4th year.
Available publications on biotechnology education in 
pharmacy schools and colleges in north America are relatively 
few but from the historical point of view this education is 
still developing. in comparison with other subjects in the 
curriculum, it started relatively recently and from the beginning 
it was focused on product knowledge, while later was further 
developed to knowledge on technology processes and 
product usage. After 2000, the biotechnology developments 
led to the creation of separated branches of science such as 
pharmacogenetics and pharmacogenomics that were included 
in the pharmacists’ postgraduate education.
The adequate reflection of recent developments in modern 
pharmaceutical science and practice driven by biotechnology 
methods in the pharmacy curriculum is very important to 
ensure safe and rational use of biopharmaceuticals. Prescribers 
need to have access to trained pharmacists who can address 
their concerns and problems. in that way payers and healthcare 
institutions would be assured that biotech drugs are being 
used properly and according to the established guidelines and 
patients and their families would receive updated information on 
modern effective therapy. thus, designation of biotechnology 
as a pharmacy specialty would be beneficial to all concerned 
parties: payers, health institutions, patients etc. As a general 
principle, the pharmacy education needs to be shaped to the 
needs of biotechnology-based pharmaceutical industry and 
clinical practice. As pharmacists accept the responsibility of 
dispensing, monitoring, and providing information about the 
new biotechnology-derived products, they will enhance the 
rational use of these pharmaceuticals (14).
in light of these considerations, it has been suggested that 
if pharmacists are to take a significant role in biotechnology 
applications in pharmacy practice, then schools of pharmacy 
need to offer a more structured, formalized process of 
teaching this important topic (8). the developments in modern 
pharmacy practice are taken into account and implemented 
in the pharmacy curriculum in the colleges and schools of 
pharmacy in the United States. in 78% of the USA universities 
this is achieved by integrating biotechnology content in the 
PharmD curriculum. Regardless of the approach chosen, 
future pharmacists are provided with knowledge, skills and 
attitudes to be more competitive in the health care system, 
pharmacy practice-related fields, pharmaceutical industry and 
drug research and development areas related to biotechnology-
derived products. educators have the responsibility to decide 
how these new directions in the education programs should 
be implemented having in mind the increasing importance of 
biotechnology-derived products in pharmacists’ daily life.
Conclusions
together with the development of biotechnology science the 
educational programs are improving but they still delay to 
provide knowledge, especially for undergraduate students. the 
educational model that dominates is more oriented towards 
inclusion of the biotechnology topics in different disciplines 
and to a lesser extent, towards providing separate topics. there 
is still no structured and unified approach to biotechnology 
education in the observed colleges.
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